RT Journal Article
SR Electronic
T1 Burden of Depressive and Anxiety Disorders in Nepal, 1990-2017: An Analysis of Global Burden of Disease Data
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.06.13.21258841
DO 10.1101/2021.06.13.21258841
A1 Bhatta, Deepa Kumari
A1 Budhathoki, Kreeti
A1 Paudel, Kiran
A1 Paudel, Shishir
A1 Marhatta, Sujan Babu
A1 Banskota, Avinaya
A1 Joshi, Yadav Prasad
YR 2021
UL http://medrxiv.org/content/early/2021/06/15/2021.06.13.21258841.abstract
AB Objectives This study aims to describe the burden of depressive and anxiety disorders in Nepal in terms of incidence, prevalence, YLDs, and DALYs by age and sex.Design An ecological study on disease burden.Methods We used the publicly available Global Burden of Disease (GBD) data from 1990 to 2017. The age and sex-specific incidence, prevalence rate, Years Lived with Disability (YLDs), and Disability Adjusted Life Years (DALYs) were examined among per 100,000 populations.Results Females had a higher prevalence of depressive 4094.4 (95% uncertainty interval [UI]: 3761.9-4470.3 per 100,000) and anxiety 4496.8 (95% UI: 4171.9-4837.9 per 100,000) disorders. The prevalence of major depressive disorders was comparatively higher in females (2766.7) than males (1822.9). Females also had higher YLDs for both depressive and anxiety disorders. In 2017, higher DALYs of anxiety disorder were found in the females of 45-49 years (630.1). Childhood sexual abuse was found to be the main risk factor for depressive disorder, contributing to 32.5 DALYs in both sexes. Bullying, victimization had contributed to 26.7 DALYs of anxiety.Conclusions The high burden of disorders in females would support in identifying major mental health challenges in Nepal and develop plans and various preventive, curative, and rehabilitative strategies.Strength and limitations of this studyThis is one of the few studies that have provided the burden of depressive and anxiety disorders in developing nations such as Nepal.The data used in this study were based on the GBD studies which utilize exhaustive information sources and comprehensive investigations.Estimation of the burden of diseases was restricted to standard epidemiological measures and other financial and social burdens were not considered.Due to use of secondary data and information which were only available publicly this may not representative of the whole nation.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialThe study used the secondary dataFunding StatementNoneAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study is based on publicly available Global Burden of Disease (GBD)dataAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data used was of Global Burden of Disease (GBD)